Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray has formed an agreement with Privateer Holdings to transfer share ownership directly to Privateer’s shareholders.

Tilray Shares Primed For A Rally

Canopy Growth

Cronos Group

CannTrust Holdings

HEXO Corp

Greenlane Holdings

Innovative Industrial Properties

Village Farms International

There's one big reason pessimism has been building for a number of popular marijuana stocks.

Short Interest Soared in May for These 8 Pot Stocks

Aurora Cannabis

Lower-valued American cannabis stocks are set to outperform their Canadian rivals as U.S. legal pot sales outpace those north of the border.

Why 5 U.S. Cannabis Stocks Will Outperform Amid Federal Ban

Popular pot stock Tilray will acquire its largest shareholder, removing fears of a future insider share dump.

Tilray Resolves a Small Issue but Bigger Problems Remain

Massive growth is coming for the global cannabis market, according to Tilray's top execs. And they think Tilray is poised to be a big winner.

5 Eyebrow-Raising Predictions From Tilray That You'll Want to Know

TLRY stock popped in early June on a lock-up extension catalyst, but that catalyst won't repeat, so more Tilray news is needed.
The post Why the Best of the Tilray Stock Rebound May Be Over appeared first on InvestorPlace.

Why the Best of the Tilray Stock Rebound May Be Over

Aphria

Cannabis stocks had a huge showing on Wall Street last fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Raise Their Bets in Cannabis Stocks

If I were a Wall Street firm, I'd have little issue handing out sell ratings to these popular pot stocks.

3 Pot Stocks Deserving of a Sell Rating

Vertically integrated Canadian company Valens GroWorks Corp. has expanded the multiyear agreement with Tilray Inc. that it signed Feb. 26.

Valens, Tilray Increase Extraction Volume, Add Manufacturing Option To Contract

Beyond Meat

Pareteum

On a positive day for the market overall, these stocks stood out.

Why Tilray, Beyond Meat, and Pareteum Jumped Today

The Canadian cannabis giant's pending deal with its majority owner is excellent news for its other shareholders.

Why Tilray Stock Is Taking Off Today

Tilray wants to extend the lockup on shares held by its largest stockholder for up to two years. Tilray stock rallied.

Tilray Stock Rallies On Lockup Plans; Other Marijuana Stocks Follow

Tilray Inc. shares jumped on Monday after the firm announced that it had signed a letter of intent with its largest stockholder, Privateer Holdings, for a transaction that will extend the lockup on and provide for the orderly release of the 75 million Tilray shares held by Privateer to Privateer’s equity holders.

Why Tilray Shares Are Lighting Up

Tilray shares moved sharply higher after Privateer announced plans to sell shares over several years rather than selling them all at once.

Tilray Breaks Out After Plan for Privateer Shares

Cannabis company Tilray Inc (NASDAQ: TLRY) said Monday it reached an agreement with its largest stockholder Privateer Holdings to extend a lockup period by two years.

Tilray Extends Lockup Period With Major Shareholder

Shares of Tilray Inc. TLRY, +8.68% shot up 8.2% in premarket trade Monday, after the Canada-based cannabis company announced an agreement that extends the lock up, and provide for the orderly sale, of the 75 million shares, or 77% of the Tilray shares outstanding, held by its largest shareholder, Privateer Holdings.

Tilray's stock surges after deal that extends lock up of shares held by largest shareholder

Tilray struck a deal with its majority shareholder, a Peter Thiel-backed fund, to sell the fund's stake gradually over the next two years, the Canadian pot company announced Monday.

Tilray and Peter Thiel-backed fund strike deal to release its shares gradually over the next two years

Despite soaring sales, the Canadian cannabis producer is struggling to turn a profit.

Why Marijuana Stock Tilray Plunged 25.9% in May

Neptune Wellness Solutions Inc.

Investors are excited about Neptune's new deal with Tilray.

Why Neptune Wellness Solutions Stock Is Soaring Today

Neptune Wellness Solutions Inc (NASDAQ: NEPT), a Canada-based company engaged in the extraction, purification and formulation of health and wellness products, has entered into a definitive agreement to provide extraction, and purification services to Tilray Inc.

Neptune Wellness Signs Extraction Deal With Tilray

Marijuana investors' favorite stocks are anywhere from 25% to 84% below their all-time highs.

Every Popular Pot Stock Is Now in Bear Market Territory

Neptune Wellness Solutions Inc. NEPT, -0.25% NEPT, +0.19% announced Friday an agreement with cannabis company Tilray Inc.

Neptune Wellness signs 3-year extraction, purification deal with cannabis company Tilray

Less than a year ago, Tilray (NASDAQ:TLRY) traded at an eye-popping $300 a share. But Sept. 19 is a long time ago in the cannabis investing world, as TLRY stock fell steadily since that time, closing yesterday at $35.70.

Here’s Why Beat-Down Tilray Stock Could Keep Dropping To As Low As $30

Cannabis stocks are getting high praise from Wall Street analysts lately, with several top companies landing new buy ratings.

Analyst Says Tilray Growth Expectations Are Way Too High

Cronos Group Inc (NASDAQ: CRON) and several other cannabis stocks have received some love from Wall Street analysts in the past week, but one analyst said Wednesday the 2019 struggles for Tilray Inc (NASDAQ: TLRY) will continue in the near term.

News for Tilray Brands Stock (TLRY)